Development and validation of a stability-indicating RP-HPLC method for the identification, determination of related substances and assay of dimethyl fumarate in drug substance (original) (raw)

A a Rapid and Sensitive RP-HPLC Method for the Quantitative Analysis of Empagliflozin in Bulk and Pharmaceutical Dosage Form

Krishnaveni Nagappan

International Journal of Applied Pharmaceutics, 2019

View PDFchevron_right

A RAPID AND SENSITIVE RP-HPLC METHOD FOR THE QUANTITATIVE ANALYSIS OF EMPAGLIFLOZIN IN BULK AND PHARMACEUTICAL DOSAGE FORM

International Journal of Applied Pharmaceutics (IJAP)

International Journal of Applied Pharmaceutics, 2019

View PDFchevron_right

Assay of empagliflozin tablets by a stability-indicating micellar electrokinetic chromatography method and cytotoxicity study of degraded samples

Andréa Adams

Brazilian Journal of Pharmaceutical Sciences

View PDFchevron_right

HPLC Method Development for the Estimation of Empagliflozin in Bulk and Pharmaceutical Formulation

Asmita Gaikwad

Journal of Pharmaceutical Research International, 2022

View PDFchevron_right

Stability Indicating, pH and pKa Dependent HPLC–DAD Method for the Simultaneous Determination of Weakly Ionizable Empagliflozin, Dapagliflozin and Canagliflozin in Pharmaceutical Formulations

Sabiha Mansoor

Chromatographia, 2020

View PDFchevron_right

Novel Simplified Analytical Method for Stress Degradation Study of Empagliflozin an Oral Anti-diabetic Agent by RP-HPLC Method

Arulselvan Murugesan

Acta Scientific Pharmaceutical Sciences, 2022

View PDFchevron_right

Development and Validation of Dapagliflozin by Reversed-Phase High-Performance Liquid Chromatography Method and It’s Forced Degradation Studies

shakir basha

Asian Journal of Pharmaceutical and Clinical Research, 2017

View PDFchevron_right

Kinetic Degradation Study of Dapagliflozin Coupled with UHPLC Separation in the Presence of Major Degradation Product and Metformin

Wafaa A Zaghary

Chromatographia, 2019

View PDFchevron_right

Simultaneous Estimation of Gliflozin Derivatives Canagliflozin, Dapagliflozin, Empagliflozin and Ertugliflozin Using RP-HPLC Methods

Arulselvan Murugesan

Acta Scientific Pharmaceutical Sciences, 2022

View PDFchevron_right

Saudi Journal of Medical and Pharmaceutical Sciences Stability Indicating Method Development and Validation for Simultaneous Estimation of Linagliptin and Empagliflozin in Tablets by HPLC

Sunand Kumar

View PDFchevron_right

Method Development, Validation by Simultaneous Estimation of Empagliflozin and Linagliptin by RP-HPLC Method

Vaibhav Khodke

Journal of Pharmaceutical & Scientific Innovation

View PDFchevron_right

Validation of a Newly Developed Stability Indicating RP-Liquid Chromatographic Method for the Quantitative Determination of Dapagliflozin

Dr. Rameswara Rao Modalavalasa

View PDFchevron_right

Stability indicating assay method for the simultaneous estimation of Empagliflozin and Metformin HCl by RP-HPLC method

Sai Charan

International Journal of Research in Pharmaceutical Sciences, 2020

View PDFchevron_right

Development and Validation of a Stability-Indicating HPLC Method for Empagliflozin and Linagliptin in Tablet Dosage Form

Israa Al-ani

Asian Journal of Chemistry, 2021

View PDFchevron_right

Validation of Stability-Indicating Reverse Phase HPLC Method for the Determination of Related Substances in Dapagliflozin Drug Substance

nowduri annapurna

American Journal of PharmTech Research, 2018

View PDFchevron_right

Novel UV and Visible Spectrophotometric methods for the analysis of Empagliflozin a type 2 diabetic drug in bulk and pharmaceutical formulations

Journal de Afrikana

View PDFchevron_right

A NOVEL STABILITY-INDICATING RP-UPLC METHOD FOR THE QUANTIFICATION OF IMPURITIES AND A NEW QDa MASS DETECTOR COUPLED WITH LC-PDA FOR IDENTIFICATION OF MASS OF DEGRADATION PRODUCTS IN A FIXED DOSE COMBINATION OF EMPAGLIFLOZIN AND LANIGLIPTIN TABLETS USED AS SECOND-LINE THERAPY FOR TYPE-2 DIABETES

varaprasad jagadabi

International Research Journal of Pharmacy, 2018

View PDFchevron_right

Development and Validation of First Order Derivative Uv-Spectrophotometric Method for Determination of Empagliflozin and Linagliptin

patel bhumi

2017

View PDFchevron_right

Spectrophotometric analysis of empagliflozin tablets as SGLT2 inhibitors in pharmaceutical samples

Mousa Magharbeh

Journal of Applied Pharmaceutical Science

View PDFchevron_right

Development and Validation of Uv Spectroscopic Method for Estimation of Empagliflozin in Rat Plasma for Pharmacokinetic Applications

Bhavik Jani

International Journal of Biology Pharmacy and Allied Sciences, 2020

View PDFchevron_right

A Review on Analytical Methods of Dapagliflozin: An Update

shilpi pathak

INTERNATIONAL JOURNAL OF PHARMACEUTICAL QUALITY ASSURANCE

View PDFchevron_right

DEVELOPMENT AND VALIDATION OF RAPID STABILITY-INDICATING HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY METHOD FOR THE DETERMINATION OF LINAGLIPTIN AND EMPAGLIFLOZIN IN PURE AND DOSAGE FORMS

Asian Journal of Pharmaceutical and Clinical Research Journal

Asian Journal of Pharmaceutical and Clinical Research, 2020

View PDFchevron_right

DEVALOPMENT AND VALIDATION OF STABILITY INDICATING QUANTITATIVE ESTIMATION OF DAPAGLIFLOZIN IN BULK AND PHARMACEUTICAL DOSAGE FORM BY RP-HPLC

Editor iajps

View PDFchevron_right

A Novel Validated Stability Indicating Analytical Method for Simultaneous Quantification of Metformin Hydrochloride and Empagliflozin in Bulk and Marketed Formulation by HPTLC using Box-Wilson Experimental Design Approach

MANOJKUMAR K. MUNDE

Indian Journal of Pharmaceutical Education and Research

View PDFchevron_right

Development and Validation of Reverse-phase HPLC method for the simultaneous determination of Empagliflozin and Metformin in Pharmaceutical Dosage Form

ravisankar sankar

High Technology Letters, 2021

View PDFchevron_right

Determination of linagliptin and empagliflozin by UPLC and HPTLC techniques aided by lean six sigma approach

ahmed naggar

Biomedical Chromatography, 2021

View PDFchevron_right

Green chromatographic methods for simultaneous micro-determination of empagliflozin, linagliptin with metformin and its pharmacopoeial impurities in pure form and triple combination tablets: A comparative study

Ola El-Shoubashy

Sustainable Chemistry and Pharmacy, 2022

View PDFchevron_right

SIMPLE QUANTIFIED AND VALIDATED STABILITY INDICATING STRESS DEGRADATION STUDIES OF ORAL ANTI-DIABETIC AGENT DAPAGLIFLOZIN BY RP-HPLC METHOD Original Article

International Journal of Applied Pharmaceutics (IJAP)

International Journal of Applied Pharmaceutics, 2022

View PDFchevron_right

Simple Quantified and Validated Stability Indicating Stress Degradation Studies of Oral Anti-Diabetic Agent Dapagliflozin by RP-HPLC Method

Arulselvan Murugesan

International Journal of Applied Pharmaceutics

View PDFchevron_right

Stability indicating HPLC-Fluorescence detection method for the simultaneous determination of linagliptin and empagliflozin in their combined pharmaceutical preparation

mona elshahed

European Journal of Chemistry

View PDFchevron_right

COMPARISON Of ACID DEGRADANT PRODUCT WITH METAbOLIC PATHWAy Of REMOGLIfLOZIN ETAbONATE IN DEvELOPED AND vALIDATED RP-HPTLC METHOD

Dr Akhil Nagar

Indian Drugs, 2022

View PDFchevron_right

Identification, isolation, and structural characterization of novel forced degradation products of Ertugliflozin using advanced analytical techniques

SURESH SALAKOLUSU 218000600

Scientific Reports

View PDFchevron_right